During the past decade, Umit Ayse Tandircioglu conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Umit Ayse Tandircioglu" are "Newborn Morbidity" (2 trials), "Hypoxic-Ischemic Encephalopathy" (1 trials) and "Neural Tube Defects" (1 trials). Many other conditions were trialed in "Umit Ayse Tandircioglu" in a lesser frequency.

Most popular intervention types in "Umit Ayse Tandircioglu" are "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "In this study, the short-term follow-up of patients with neural tube defects in the neonatal intensive care unit will be evaluated retrospectively." (1 trials) and "no intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Umit Ayse Tandircioglu" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Umit Ayse Tandircioglu". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Umit Ayse Tandircioglu, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Umit Ayse Tandircioglu, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".